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Background: Allergic diseases represent a frequent and increasing condition affecting chil-
dren. A screening questionnaire allowing an easy identification of children with symptoms of 
allergic diseases may improve management and clinical outcome. The aim of this study was to 
develop and validate an easy-to-use screening questionnaire to detect children requiring further 
allergological evaluations.
Methods: A 10-item questionnaire, evaluating the presence and the history of the most frequent 
allergic conditions affecting children, including allergic asthma, allergic rhinitis and conjunc-
tivitis, food allergy, and atopic dermatitis, was developed and administered to 214 parents of 
children from 5 to 10 years of age (163 with allergic disease and 51 healthy, nonallergic chil-
dren). Validation was performed by Pearson’s correlation between the clinical diagnosis and 
the responses to the questionnaire. Internal consistency was computed by Cronbach’s alpha 
correlation coefficient. Sensitivity and specificity of the novel questionnaire were assessed by 
the receiver operating characteristic (ROC) curve.
Results: Validation analysis of the new children atopy (ChAt) questionnaire showed good 
internal consistency with a Cronbach’s alpha of 0.757. Responses to the items evaluating the 
presence of individual allergic conditions significantly correlated with the clinical diagnosis 
(p<0.001). The ROC curve showed an area of 0.956 and identified a cutoff value >2 of the ChAt 
questionnaire total score for detection of allergy (sensitivity =0.92 and specificity =0.902). 
Conclusion: The novel ChAt questionnaire represents a simple tool able to detect the presence 
of all major allergic diseases in a pediatric population allowing an early identification of allergic 
multimorbidity and potentially facilitating clinical management.
Keywords: allergy, questionnaire, children, screening, validation
Introduction
Allergic diseases represent a leading cause of chronic illness in children, with up to 
30% of pediatric population affected by some form of atopic disease.1–3 Moreover, 
the prevalence of allergy seems to have dramatically increased over the past 25 years, 
particularly in Western industrialized countries.4,5 Among the Italian children, preva-
lence of allergic disorders varies from 20% for rhinitis to 10% for eczema/dermatitis, 
9% for asthma, and 8% for food allergy.6–8
Since allergic inflammation involves different target tissues (conjunctiva, nose, 
lung, and skin) causing allergic conjunctivitis (AC), rhinitis (AR), asthma symptoms, 
and atopic eczema/dermatitis, evaluation of the prevalence of allergic diseases requires 
that any form of allergic response should be identified and addressed.9 In fact, atopic 
conditions are often comorbid: 20%–40% of patients with AR are reported to have 
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asthma, and 30%–90% of patients with asthma have AR.10,11 
In addition, it has been proposed that early diagnosis and treat-
ment should improve clinical outcome of allergy in children 
by controlling the progression toward the most severe forms, 
such as allergic asthma.4 Therefore, screening instruments, 
allowing an early and simple identification of children with 
suspected allergic conditions, may improve patients’ health 
and clinical outcomes.12,13 Questionnaires are useful screen-
ing tools with the advantages of being noninvasive, low cost, 
and easy to administer and provide quick results. 13–15 Aller-
gic screening questionnaires for school children have been 
developed for the detection of individual allergic conditions 
to improve early identification and management of allergic 
diseases.12,16–18- Most of them are focused primarily on detec-
tion and/or prediction strategies of asthma, with comorbid 
allergic diseases, including rhinitis and conjunctivitis, used to 
increase the specificity of allergic diseases detection.17–22- In 
this study, to identify the children with symptoms of all the 
major allergic disease types, we developed and validated a 
novel, simple, and easy-to-use children atopy (ChAt) question-
naire that addresses the primary allergic conditions. 
Methods
Children between 5 and 10 years of age were recruited con-
secutively by the Pediatric Allergology and Immunology Unit, 
Policlinico Tor Vergata, University of Rome Tor Vergata, Italy, 
for the development and initial validation phases of the new 
screening questionnaire for the detection of allergic diseases 
in children (ChAt questionnaire). 
The study was conducted in accordance with the prin-
ciples embodied in the Declaration of Helsinki of 1965 
(as revised in Brazil 2013). All parents of the participants 
provided written informed consent, and patient anonymity 
was preserved using methods approved by the Local Ethics 
Committee of the University of Rome Tor Vergata. 
Diagnosis of allergic diseases including AC, AR, allergic 
asthma, atopic dermatitis, and food allergy was based on 
clinical history, objective examination, and allergological 
exams (including skin prick tests and specific Immunoglobu-
lin (Ig) E detection). 
ChAt screening questionnaire 
development
The development of ChAt screening questionnaire included 
the following steps.23,24
1. Item generation. The aim of this phase was to identify 
the items and conditions to be included in the screening 
questionnaire. A preliminary list of items was developed 
on the basis of the following sources:
•	 An international literature review was performed 
through a computerized search in the Medline data-
base to identify existing screening questionnaires for 
allergic diseases in children by using the following 
keywords/search terms: atopy*, allergy*, asthma*, 
allergic conjunctivitis*, allergic rhinoconjunctivitis* 
atopic dermatitis*, food* and allergy, children ques-
tionnaire and screening questionnaire.
•	 A panel of four specialists (VM, LC, MS, AL) were 
required to indicate the most frequent allergic con-
ditions affecting children and how to identify them 
through simple questions for administration to the 
parents.
2. Item reduction. A qualitative selection was performed 
from the preliminary list of items by eliminating those 
which were redundant, difficult to understand, or ambigu-
ous. The resulting screening questionnaire included 10 
items aimed at identifying a history of allergic diseases 
and the presence of specific symptoms of allergy: 1) previ-
ous diagnosis of allergic diseases, 2) previous use of antial-
lergic drugs, 3) presence of symptoms of AC, 4) presence 
of symptoms of AR, 5) presence of symptoms of asthma, 
6) presence of symptoms of atopic dermatitis, 7) history 
of severe allergic conditions such as anaphylaxis, 8) peren-
nial and/or seasonal presentation of allergic symptoms, 9) 
family history of allergic diseases, and 10) history of food 
allergy including elimination diet (Table 1).
Cognitive debriefing interviews with 10 parents of allergic 
children were performed to verify that the items were clear 
and easy to understand. The screening questionnaire was 
administered to the patient population for initial validation. 
Validation of the new ChAt 
questionnaire 
Two-hundred and fourteen parents of children between 5 and 
10 years of age completed the screening questionnaire. One-
hundred and sixty-three children were diagnosed with one or 
more allergic diseases by allergological exam, and in 51 chil-
dren allergic diseases were excluded. This group was utilized 
as the healthy control group for the validation of the ChAt 
questionnaire. The aim of the validation phase was to evaluate 
the following psychometric properties of the new instrument:
•	 Validity: using the Pearson correlation coefficient, we 
evaluated the relationship between the clinical diagnosis 
and the responses to the questionnaire.13 
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•	 Internal consistency: a measure of the homogeneity of a 
scale was computed using the Cronbach’s alpha correla-
tion coefficient, and test–retest reliability, was evaluated 
by using intraclass correlation coefficient (ICC). Mea-
surements with reliability of 0.70 or more have been 
recommended for the purpose of comparing groups.14
Discriminant validity was evaluated by comparing the 
scores of allergic patients. Sensitivity and specificity of 
the new ChAt questionnaire were assessed by the receiver 
operating characteristic (ROC) curve in the entire popula-
tion included in this study. The type and number of allergic 
diseases affecting the children were related to the ChAt total 
score by Sperman’s rho test.
The statistically significant cutoff value was set at p<0.05. 
The entire statistical analysis was conducted by using SPSS 
software version 18.0.
Results
Parents of one-hundred sixty-three allergic (N=163, mean 
age 7.2±1.1 years, 63 girls and 100 boys) and non allergic 
(N=51, mean age 7±0.9 years, 19 girls and 32 boys) children 
(mean age 7.2±1 years, 132 boys and 82 girls) completed the 
screening questionnaire. 
Among the allergic children, 97 (59.5%) patients had a clini-
cal diagnosis of AR, 51 (31%) of AC, 57 (35%) of asthma, 68 
(42%) of atopic dermatitis, and 11 (7%) of food allergy. Eighty-
nine of the 163 (55%) allergic patients were diagnosed with 
more than one allergic condition (59 had been diagnosed with 
2 different allergic diseases, 27 with 3, and 3 with 4; Table 2).
The completion of the questionnaire by parents of allergic 
children included in the study is summarized in Figure 1.
Validation analyses were undertaken considering the 
group of allergic patients (N=163).
1. Validity. Item and scale scores were oriented so that No= 
0 and Yes =1 (Table 1); the sum of scores ranges between 
0 and 10, and the higher the score, the higher probability 
to have an allergic disease. 
2. Internal consistency. The screening questionnaire dem-
onstrated satisfactory Cronbach’s alpha value of 0.757 
and ICC of 0.84. 
Table 1 chat questionnaire items and score values
Screening questionnaire for allergic diseases in children 
(to be completed by parents)
Response scores 
Yes No
 1. Was your child diagnosed with an allergic disease? 
	 if yes, please specify: 
-	 allergic asthma
-	 allergic rhinitis
-	 allergic conjunctivitis
-	 Hives
-	 atopic dermatitis
-	 Food allergy (with elimination diet)
-	 anaphylaxis
1 0
 2. Did your child ever use drugs for an allergic disease? (e.g., antihistamines, corticosteroids, etc.) 1 0
 3. Does your child often show red eyes, tearing, and itching? 1 0
 4. Does your child sneeze often or does he/she have nasal itching and discharge? 1 0
 5.  Did your child ever complain of breathing problems? (e.g., shortness of breath, chest tightness, wheezy 
breathing, coughing, or itchy throat) 
1 0
 6. Does your child often have dermatitis with itching? 1 0
 7. Did your child ever suffer with severe allergic reactions or anaphylactic shock? 1 0
 8.  Does your child have any of the above symptoms? 
	 if yes, please specify if:
-	 seasonal: spring/summer or autumn/winter
-	 Throughout the year 
1 0
 9. Does your child have relatives who suffer or have suffered of an allergic disease? 1 0
10. Did your child ever have allergic reactions to food? 
	 if yes, please specify:
-	 asthma
-	 Dermatitis
-	 rhinoconjunctivitis
currently, is he/she under an elimination diet? 1 0
Abbreviation: chat, children atopy.
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A strong correlation was observed between the clinical 
diagnosis and the responses to the questionnaire. Specifically, 
the following items showed strong correlation: 
•	 Item 3 – clinical diagnosis of AC vs symptoms of AC 
(p<0.001, R=0.330)
•	 Item 4 – clinical diagnosis of AR vs symptoms of AR 
(p<0.0001, R=0.467)
•	 Item 5 – clinical diagnosis of allergic asthma vs symptoms 
of allergic asthma (p<0.0001, R=0.527)
•	 Item 6 – clinical diagnosis of atopic dermatitis vs symp-
toms of atopic dermatitis (p<0.0001, R=0.483)
•	 Item 9 – familiar history of allergic disease collected by 
physician vs positive response to familiar history in the 
questionnaire (p<0.0001, R=0.368)
•	 Item 10 – presence of food allergy diagnosed by allergolo-
gist vs positive response to food allergy with elimination 
diet in the questionnaire (p<0.0001, R=0.370)
Table 2 clinical characteristics of allergic population included in 
the study
Clinical characteristics Allergic children (N=163)
Age (years)
range 
Mean±sD
5–10
7±0.9
Gender
Males
Females
100
63
Single allergic condition
Multiple allergic conditions
74 (45%)
89 (55%)
Allergic diseases diagnosis 
allergic rhinitis 
allergic conjunctivitis 
asthma
atopic dermatitis 
Food allergy
97 (59.5%)
51 (31%)
57 (35%)
68 (42%)
11 (7%)
Skin prick tests 
negative
Positive
not done
16 (10%)
126 (77%)
21 (13%)
Figure 1 Percentage of positive responses to the chat questionnaire items.
Abbreviation: chat, children atopy.
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The ROC curve was calculated including the entire popu-
lation of allergic and nonallergic children. Results showed 
an area of 0.956 and suggested that a cutoff score of >2 was 
able to accurately identify the allergic population with a 
sensitivity value of 0.920 and specificity of 0.902 (Figure 2).
Patients with a diagnosis of allergy showed an average 
ChAt questionnaire score of 5.2±2, while nonallergic patients 
showed an average of 1.2±1.2, confirming that the cutoff total 
score >2 is able to identify the allergic population. In addition, 
the number of allergic diseases affecting the children was sig-
nificantly related to the ChAt total score (p<0.001, R=0.695).
ChAt questionnaires with total score >2 identified a 
population with the possible presence of allergy which 
requires further clinical investigation for allergic disease, 
with a sensitivity of 92% (95% CI: 86.75% to 95.69%) and 
a specificity of 90% (95% CI: 78.59% to 96.74%), a positive 
likelihood ratio (LR) of 9.39 (95% CI: 4.08 to 21.61) and 
negative LR of 0.09 (95% CI: 0.05 to 0.15).
Discussion
Atopic diseases represent a substantial burden on the health 
care system, and great attention should be paid to identify 
children with allergic diseases in a timely manner and to pro-
vide prompt treatment and management of allergic diseases.25 
Several screening tools, including screening questionnaires 
and prediction rules, have been developed to detect specific 
allergic conditions and the risk of progression toward more 
severe allergic conditions such as asthma.17,18,24 Since a simple 
and ready-to-use tool for the identification of children with 
allergic symptoms including all the most common symptoms 
of allergic diseases is not currently available, in this study we 
developed and validated a new 10-item screening question-
naire to identify children with allergic symptoms requiring 
further clinical evaluation. This questionnaire represents a use-
ful tool for the detection of children with suspicion of allergy 
in epidemiological, screening studies or in general practice.
Most studies commonly use questionnaires to collect epi-
demiological and clinical data. Moreover, self-administration 
of questionnaires avoids interviewer bias.17,18,26,27 On the 
other hand, the main issue in the validation process of self-
administered questionnaires is the capability to understand 
the items and to appropriately answer them. To facilitate this 
process, the ChAt questionnaire has been developed with 
well-defined, objective, and easily understandable questions 
for parent self-administration. In addition, respondents were 
selected and screened from the same geographical area 
(Rome, Italy).28
The ChAt questionnaire includes an item exploring the 
previous diagnosis of allergic conditions, with specification 
of the previous diagnosis, and an item about the previous use 
of antiallergic drugs to aid in the identification of allergic 
children. The other five items explore the presence of the most 
frequent symptoms associated with AC, AR, asthma, atopic 
dermatitis, and food allergy including elimination diet. The 
responses to these items showed a significant correlation with 
the clinical diagnosis of the specific allergic condition made by 
the allergologist, suggesting the ability of the items to identify 
the presence of the symptoms of specific disease. An additional 
three items evaluate the history of severe allergic reactions 
such as anaphylaxis, seasonal and/or perennial symptoms’ 
presentation, and familial history of allergy, adding important 
information for the identification of allergic children. 
The ChAt score was calculated by the sum of the “YES” 
responses to the 10 items resulting in a total score ranging 
from 0–10, with the higher total score indicating a higher 
probability of allergy. The ROC curve analysis showed that 
a ChAt questionnaire total score >2 was able to identify 
children having allergy with high levels of sensitivity (92%) 
and specificity (90%). 
Therefore, this study describes the development and 
preliminary validation of a simple, standardized, 10-item 
screening questionnaire that is able to identify atopic chil-
dren who should be evaluated for the presence of allergic 
diseases and allergic comorbidities. The ChAt questionnaire 
shows the limitations characteristic of the use of question-
naires for disease screening, which includes the need to 
demonstrate the validity in different settings, in terms of 
Figure 2 receiver operating characteristic (rOc) curve of chat questionnaire 
scores for identification of the presence of allergic diseases. 
Abbreviation: chat, children atopy.
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sample  population, social conditions, and geographic dis-
tribution, and to standardize the clinical diagnosis of the 
specific allergic conditions to be used as “gold standard.” 
12–15,17–19,28 An epidemiological study is currently ongoing 
in a large population of schoolchildren to confirm the 
validity of the ChAt questionnaire at identifying children 
with allergic symptoms and allowing an early diagnosis of 
“unknown” cases. 
Assessing allergic diseases at a community level using 
simple questionnaires, such as ChAt, may be a first step to 
change patient behaviors and to target educational initiatives 
aimed at improving the allergic disease outcomes. In fact, 
not only is poor disease control a negative prognostic factor 
for allergic disease progression, but it may also be associ-
ated with low continuity of care due to a poor  doctor–patient 
relationship, negative attitudes, and concerns about the use 
of medication, and little understanding of the disease.10,29 
The consequences of such a scenario are detrimental for 
atopic children, their families, and the health care system 
in general.
To conclude, the ChAt questionnaire represents a useful 
tool to identify children with suspicion of multiple atopic 
conditions and, in turn, to substantially contribute to further 
enhance the treatment and clinical management of allergic 
diseases. In addition, the ChAt questionnaire may facilitate 
the collection of data on school children population, which 
could be useful to save time and serve as useful resource in 
large epidemiological studies.
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